Trial · NCT01331837
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to First Cardiovascular (CV) Events Adjudication Committee (EAC) (CV-EAC) Adjudicated Event | Tocilizumab | NA | 95% Confidence Interval NA to NA | Months | |
| Time to First Cardiovascular (CV) Events Adjudication Committee (EAC) (CV-EAC) Adjudicated Event | Etanercept | NA | 95% Confidence Interval NA to NA | Months | |
| Percentage of Patients Reporting a Cardiovascular (CV) Events Adjudication Committee (EAC) (CV-EAC) Adjudicated Event | Tocilizumab | 5.4 | Percentage of patients with event | ||
| Percentage of Patients Reporting a Cardiovascular (CV) Events Adjudication Committee (EAC) (CV-EAC) Adjudicated Event | Etanercept | 5.1 | Percentage of patients with event | ||
| Time to First CV-EAC Adjudicated Event - Sensitivity Analysis | Tocilizumab | NA | 95% Confidence Interval NA to NA | Months | |
| Time to First CV-EAC Adjudicated Event - Sensitivity Analysis | Etanercept | NA | 95% Confidence Interval NA to NA | Months | |
| Percentage of Patients With a CV-EAC Adjudicated Event - Sensitivity Analysis | Tocilizumab | 3.7 | Percentage of patients with event | ||
| Percentage of Patients With a CV-EAC Adjudicated Event - Sensitivity Analysis | Etanercept | 3.4 | Percentage of patients with event | ||
| Time to First CV-EAC Adjudicated Event Excluding Undetermined Cause of Death - Sensitivity Analysis | Tocilizumab | NA | 95% Confidence Interval NA | Months | |
| Time to First CV-EAC Adjudicated Event Excluding Undetermined Cause of Death - Sensitivity Analysis | Etanercept | NA | 95% Confidence Interval NA | Months | |
| Percentage of Patients With a CV-EAC Adjudicated Event Excluding Undetermined Cause of Death - Sensitivity Analysis | Tocilizumab | 4.8 | Percentage of patients with event | ||
| Percentage of Patients With a CV-EAC Adjudicated Event Excluding Undetermined Cause of Death - Sensitivity Analysis | Etanercept | 4.7 | Percentage of patients with event | ||
| Time to First CV-EAC Adjudicated Event Before Last Direct Contact Date | Tocilizumab | NA | 95% Confidence Interval NA | Months | |
| Time to First CV-EAC Adjudicated Event Before Last Direct Contact Date | Etanercept | NA | 95% Confidence Interval NA | Months | |
| Percentage of Participants With a CV-EAC Adjudicated Event Before Last Direct Contact Date | Tocilizumab | 3.2 | Percentage of participants with event | ||
| Percentage of Participants With a CV-EAC Adjudicated Event Before Last Direct Contact Date | Etanercept | 3.0 | Percentage of participants with event | ||
| The Time to First Occurrence of an Expanded CV Composite Endpoint | Tocilizumab | NA | 95% Confidence Interval NA | Months | |
| The Time to First Occurrence of an Expanded CV Composite Endpoint | Etanercept | NA | 95% Confidence Interval NA | Months | |
| Percentages of Participants With an Expanded CV Composite Endpoint | Tocilizumab | 5.5 | Percentages of participants | ||
| Percentages of Participants With an Expanded CV Composite Endpoint | Etanercept | 5.4 | Percentages of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01331837/results